Ultra-Long Peripheral Catheter Versus Accelerated Seldinger Technique Long Peripheral Catheter in Difficult IV Access Patients
Launched by UNIVERSITY GHENT · Jun 2, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different ways to place a long peripheral catheter in adults who have difficult intravenous (IV) access. A peripheral catheter is a small tube that doctors place into a vein to give treatments like medications or fluids. The study will compare an ultra-long peripheral catheter technique with an accelerated method called the Seldinger Technique to see which one works better for patients. Researchers will check if one method allows the catheter to stay in place longer and is easier to use, while also looking for any potential issues like infections or complications that might arise from using these catheters.
To participate in this study, you must be an adult patient who is currently in the hospital and needs a long peripheral catheter because you have trouble with IV access. You should be able to understand either Dutch or French and have the ability to make decisions about your care, or have a legal representative who can help. If you're interested, the study will explain what to expect during the process, and you'll be closely monitored for any side effects or complications. It's important to note that if you only need IV treatment for less than 24 hours or have certain medical conditions, you may not be eligible for this trial.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult inpatients with DIVA, requiring placement of a long peripheral catheter, will be included in the study.
- • A digital request form for venous access must be completed by the treating physician at the ward.
- • Patients must be proficient in either Dutch or French
- • Patients must have decision-making capacity or be represented by a legal representative.
- Exclusion Criteria:
- • Expected therapy duration of less than 24 hours
- • pregnancy
- • Need for central venous access
- • Inability to locate a deep peripheral vein in the upper extremity prior enrollment in the study
- • Veins located deeper than 1.6cm prior enrollment in the study
- • withdrawal of consent, or presentation at a time when study personnel are unavailable.
About University Ghent
University Ghent is a prestigious Belgian research institution renowned for its commitment to advancing medical science and improving patient care through innovative clinical trials. With a multidisciplinary approach, the university fosters collaboration among leading experts in various fields, ensuring rigorous study design and ethical standards. University Ghent is dedicated to exploring new therapeutic modalities and enhancing healthcare outcomes, making significant contributions to both local and global health landscapes. Its state-of-the-art facilities and emphasis on research excellence position it as a pivotal sponsor in the realm of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Brussels, Jette, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported